These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12499038

  • 1. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse.
    Pretorius ES, Timbers K, Malamud D, Barnhart K.
    Contraception; 2002 Dec; 66(6):443-51. PubMed ID: 12499038
    [Abstract] [Full Text] [Related]

  • 2. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF, Trottier S, Brousseau G, Lamarre A, Alexandre Gagnon, Bergeron MG.
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [Abstract] [Full Text] [Related]

  • 3. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.
    Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D.
    Contraception; 2004 Dec; 70(6):498-505. PubMed ID: 15541413
    [Abstract] [Full Text] [Related]

  • 4. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D.
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [Abstract] [Full Text] [Related]

  • 5. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
    Omar RF, Trottier S, Brousseau G, Ouellet C, Danylo A, Ong T, Bergeron MG.
    J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K, Kulp JL, Rosen M, Shera DM.
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [Abstract] [Full Text] [Related]

  • 7. Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract.
    Barnhart KT, Stolpen A, Pretorius ES, Malamud D.
    Hum Reprod; 2001 Jun; 16(6):1151-4. PubMed ID: 11387285
    [Abstract] [Full Text] [Related]

  • 8. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW, Joanis C, Hartmann M, Milford C, Smit J, Beksinska M, Rambally-Greener L, Pienaar J, Mabude Z, Butterworth GAM, Sokal D, Jenkins D.
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [Abstract] [Full Text] [Related]

  • 9. A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule.
    Fuchs EJ, Schwartz JL, Friend DR, Coleman JS, Hendrix CW.
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1109-15. PubMed ID: 26077739
    [Abstract] [Full Text] [Related]

  • 10. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.
    Su HI, Schreiber CA, Fay C, Parry S, Elovitz MA, Zhang J, Shaunik A, Barnhart K.
    Contraception; 2011 Nov; 84(5):525-32. PubMed ID: 22018129
    [Abstract] [Full Text] [Related]

  • 11. Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging.
    Barnhart K, Pretorius ES, Stolpen A, Malamud D.
    Fertil Steril; 2001 Jul; 76(1):189-95. PubMed ID: 11438341
    [Abstract] [Full Text] [Related]

  • 12. An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.
    Pentlicky S, Rosen M, Coffey PS, Kilbourne-Brook M, Shaunik A, Schreiber CA, Barnhart K.
    Contraception; 2013 Feb; 87(2):187-92. PubMed ID: 22898358
    [Abstract] [Full Text] [Related]

  • 13. Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2.5 and 3.5 mL).
    Barnhart KT, Pretorius ES, Shaunik A, Timbers K, Nasution M, Mauck C.
    Contraception; 2005 Jul; 72(1):65-70. PubMed ID: 15964295
    [Abstract] [Full Text] [Related]

  • 14. The optimal analysis of MRI data to quantify the distribution of a microbicide.
    Barnhart KT, Pretorius ES, Shera DM, Shabbout M, Shaunik A.
    Contraception; 2006 Jan; 73(1):82-7. PubMed ID: 16371301
    [Abstract] [Full Text] [Related]

  • 15. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
    Beksinska M, Greener R, Smit J, Maphumulo B, Mphili N, Kilbourne-Brook M, Coffey PS.
    AIDS Behav; 2018 Jan; 22(1):127-132. PubMed ID: 28993940
    [Abstract] [Full Text] [Related]

  • 16. An overview of properties of Amphora (Acidform) contraceptive vaginal gel.
    Nelson AL.
    Expert Opin Drug Saf; 2018 Sep; 17(9):935-943. PubMed ID: 30136907
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.
    Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
    [Abstract] [Full Text] [Related]

  • 18. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
    D'Cruz OJ, Yiv SH, Uckun FM.
    AAPS PharmSciTech; 2001 Apr 09; 2(2):E5. PubMed ID: 14727880
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.